Long-Term Risk of Skin Cancer and Lymphoma in Users of Topical Tacrolimus and Pimecrolimus: Final Results from the Extension of the Cohort Study Protopic Joint European Longitudinal Lymphoma and Skin Cancer Evaluation (JOELLE)-Reference-Cited by-同舟云学术

Long-Term Risk of Skin Cancer and Lymphoma in Users of Topical Tacrolimus and Pimecrolimus: Final Results from the Extension of the Cohort Study Protopic Joint European Longitudinal Lymphoma and Skin Cancer Evaluation (JOELLE)

Published:2021-12 Issue: Volume:Volume 13 Page:1141-1153
ISSN:1179-1349
Container-title:Clinical Epidemiology
language:en
Short-container-title:CLEP

Author:

Arana Alejandro,Pottegård Anton^ORCID,Kuiper Josephina G^ORCID,Booth Helen,Reutfors Johan^ORCID,Calingaert Brian^ORCID,Lund Lars Christian,Crellin Elizabeth^ORCID,Schmitt-Egenolf Marcus,Kaye James A^ORCID,Gembert Karin,Rothman Kenneth J,Kieler Helle,Dedman Daniel^ORCID,Houben Eline,Gutiérrez Lia^ORCID,Hallas Jesper^ORCID,Perez-Gutthann Susana^ORCID

Publisher

Informa UK Limited

Subject

Epidemiology

Reference22 articles.

1. Validation of asthma and eczema in population-based Swedish drug and patient registers

2. Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis

3. A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation – JOELLE study)

4. Association Between Topical Calcineurin Inhibitor Use and Risk of Cancer, Including Lymphoma, Keratinocyte Carcinoma, and Melanoma

5. Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reverse causation bias: A simulation study comparing first- and second-line treatments with an overlap of symptoms between treatment indication and studied outcome;PLOS ONE;2024-07-12

2. Expert Recommendations on Use of Topical Therapeutics for Vitiligo in Pediatric, Adolescent, and Young Adult Patients;JAMA Dermatology;2024-04-01

3. Sigmoid Colon Perforation in Diffuse Large B-Cell Lymphoma Due to Tacrolimus-Induced Immunodeficiency: A Case Report;Cureus;2024-02-20

4. Tumorigenic role of tacrolimus through mTORC1/C2 activation in post-transplant renal cell carcinomas;British Journal of Cancer;2024-02-10

5. Advances in the treatment of mycoses fungoides and Sézary syndrome: a narrative update in skin-directed therapies and immune-based treatments;Frontiers in Immunology;2023-10-05